JPH10503510A - ストレプトグラミン誘導体、その製造およびそれを含む製薬組成物 - Google Patents
ストレプトグラミン誘導体、その製造およびそれを含む製薬組成物Info
- Publication number
- JPH10503510A JPH10503510A JP8506254A JP50625496A JPH10503510A JP H10503510 A JPH10503510 A JP H10503510A JP 8506254 A JP8506254 A JP 8506254A JP 50625496 A JP50625496 A JP 50625496A JP H10503510 A JPH10503510 A JP H10503510A
- Authority
- JP
- Japan
- Prior art keywords
- pristinamycin
- methyl
- broad
- aromatic
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.一般式: 式中、 −基R1はメチルまたはエチル基を表し、 −基R2は、塩素もしくは臭素原子を表すか、またはもしR3およびR4がメチ ル基ならば3−5個の炭素原子を含有するアルケニル基を表し、そして −記号R3およびR4は:一方が水素原子またはメチル基であり、そして他方が メチル基である、 のストレプトグラミン誘導体。 2.R2が塩素または臭素原子である請求の範囲第1項に記載のストレプトグラ ミンの製造法であって、対応するN-ハロスクシンイミド誘導体を、R2が水素原 子であるプリスチナマイシンIに作用させることを特徴する上記方法。 3.R2が3−5個の炭素原子を含有するアルケニル基である請求の範囲第1項 に記載のストレプトグラミン誘導体の製造法であって、一般式 : 式中、R1は上記定義の通りであり、R5、R6、R7およびR8は水素原子また はメチル基であり、ただしそれらの中の少なくとも2つは水 の4-N-アルケニルアンモニオ プリスチナマイシンIAから誘導された塩を塩基 性の媒質中で転位することを特徴とする、上記方法。 4.請求の範囲第1項に記載の少なくとも1つのストレプトグラミン誘導体を、 純粋な状態で、あるいはプリスチナマイシンIIと組み合わせた状態で、および/ または場合によっては1つ以上の適合性があり、かつ薬学的に許容できる希釈剤 または賦形剤と組み合わせた状態で成ることを特徴とする、医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9409563A FR2723372B1 (fr) | 1994-08-02 | 1994-08-02 | Nouveaux derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR94/09563 | 1994-08-02 | ||
PCT/FR1995/001025 WO1996004299A1 (fr) | 1994-08-02 | 1995-07-31 | Derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005148164A Division JP4277015B2 (ja) | 1994-08-02 | 2005-05-20 | ストレプトグラミン誘導体、その製造およびそれを含む製薬組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH10503510A true JPH10503510A (ja) | 1998-03-31 |
JP3775686B2 JP3775686B2 (ja) | 2006-05-17 |
Family
ID=9465983
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50625496A Expired - Fee Related JP3775686B2 (ja) | 1994-08-02 | 1995-07-31 | ストレプトグラミン誘導体、その製造およびそれを含む製薬組成物 |
JP2005148164A Expired - Fee Related JP4277015B2 (ja) | 1994-08-02 | 2005-05-20 | ストレプトグラミン誘導体、その製造およびそれを含む製薬組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005148164A Expired - Fee Related JP4277015B2 (ja) | 1994-08-02 | 2005-05-20 | ストレプトグラミン誘導体、その製造およびそれを含む製薬組成物 |
Country Status (21)
Country | Link |
---|---|
US (1) | US5786449A (ja) |
EP (1) | EP0772630B1 (ja) |
JP (2) | JP3775686B2 (ja) |
KR (1) | KR970704463A (ja) |
AT (1) | ATE205853T1 (ja) |
AU (1) | AU696226B2 (ja) |
BR (1) | BR9508793A (ja) |
CA (1) | CA2196102A1 (ja) |
CZ (1) | CZ284383B6 (ja) |
DE (1) | DE69522810T2 (ja) |
DK (1) | DK0772630T3 (ja) |
ES (1) | ES2162932T3 (ja) |
FR (1) | FR2723372B1 (ja) |
GR (1) | GR3036908T3 (ja) |
MX (1) | MX9700712A (ja) |
NO (1) | NO970240D0 (ja) |
NZ (1) | NZ290436A (ja) |
PL (1) | PL318435A1 (ja) |
PT (1) | PT772630E (ja) |
SK (1) | SK14297A3 (ja) |
WO (1) | WO1996004299A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2775288B1 (fr) * | 1998-02-26 | 2000-03-31 | Rhone Poulenc Rorer Sa | Derives de streptogramines, leur preparation et les compositons qui les contiennent |
FR2796949B1 (fr) | 1999-07-27 | 2001-09-21 | Aventis Pharma Sa | Derives de streptogramines, leur preparation et les compositions qui les contiennent |
WO2001007467A1 (fr) * | 1999-07-27 | 2001-02-01 | Aventis Pharma S.A. | Derives de streptogramines, leur preparation et les compositions qui les contiennent |
FR2796950B1 (fr) * | 1999-07-27 | 2001-09-21 | Aventis Pharma Sa | Derives de streptogramines, leur preparation et les compositions qui les contiennent |
EP3661504A4 (en) * | 2017-08-01 | 2021-10-13 | The Regents of The University of California | METHODS FOR THE PREPARATION OF STREPTOGRAMINE COMPOSITIONS AND THE USE OF THE SAME |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2549062B1 (fr) * | 1983-07-13 | 1985-10-25 | Rhone Poulenc Sante | Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent |
-
1994
- 1994-08-02 FR FR9409563A patent/FR2723372B1/fr not_active Expired - Fee Related
-
1995
- 1995-07-31 AU AU31173/95A patent/AU696226B2/en not_active Ceased
- 1995-07-31 SK SK142-97A patent/SK14297A3/sk unknown
- 1995-07-31 BR BR9508793A patent/BR9508793A/pt not_active Application Discontinuation
- 1995-07-31 PT PT95926995T patent/PT772630E/pt unknown
- 1995-07-31 DK DK95926995T patent/DK0772630T3/da active
- 1995-07-31 ES ES95926995T patent/ES2162932T3/es not_active Expired - Lifetime
- 1995-07-31 WO PCT/FR1995/001025 patent/WO1996004299A1/fr active IP Right Grant
- 1995-07-31 US US08/776,665 patent/US5786449A/en not_active Expired - Lifetime
- 1995-07-31 CA CA002196102A patent/CA2196102A1/fr not_active Abandoned
- 1995-07-31 JP JP50625496A patent/JP3775686B2/ja not_active Expired - Fee Related
- 1995-07-31 AT AT95926995T patent/ATE205853T1/de not_active IP Right Cessation
- 1995-07-31 CZ CZ97300A patent/CZ284383B6/cs not_active IP Right Cessation
- 1995-07-31 KR KR1019970700653A patent/KR970704463A/ko not_active Application Discontinuation
- 1995-07-31 PL PL95318435A patent/PL318435A1/xx unknown
- 1995-07-31 NZ NZ290436A patent/NZ290436A/en unknown
- 1995-07-31 MX MX9700712A patent/MX9700712A/es unknown
- 1995-07-31 EP EP95926995A patent/EP0772630B1/fr not_active Expired - Lifetime
- 1995-07-31 DE DE69522810T patent/DE69522810T2/de not_active Expired - Lifetime
-
1997
- 1997-01-20 NO NO970240A patent/NO970240D0/no unknown
-
2001
- 2001-10-17 GR GR20010400675T patent/GR3036908T3/el not_active IP Right Cessation
-
2005
- 2005-05-20 JP JP2005148164A patent/JP4277015B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GR3036908T3 (en) | 2002-01-31 |
SK14297A3 (en) | 1997-08-06 |
ATE205853T1 (de) | 2001-10-15 |
PT772630E (pt) | 2002-02-28 |
NO970240L (no) | 1997-01-20 |
MX9700712A (es) | 1997-05-31 |
FR2723372B1 (fr) | 1996-10-04 |
JP3775686B2 (ja) | 2006-05-17 |
PL318435A1 (en) | 1997-06-09 |
WO1996004299A1 (fr) | 1996-02-15 |
NO970240D0 (no) | 1997-01-20 |
BR9508793A (pt) | 1997-12-23 |
EP0772630B1 (fr) | 2001-09-19 |
DE69522810T2 (de) | 2002-04-04 |
NZ290436A (en) | 1998-07-28 |
DK0772630T3 (da) | 2001-11-26 |
AU696226B2 (en) | 1998-09-03 |
ES2162932T3 (es) | 2002-01-16 |
AU3117395A (en) | 1996-03-04 |
DE69522810D1 (de) | 2001-10-25 |
US5786449A (en) | 1998-07-28 |
CA2196102A1 (fr) | 1996-02-15 |
JP2005290012A (ja) | 2005-10-20 |
CZ284383B6 (cs) | 1998-11-11 |
CZ30097A3 (en) | 1997-05-14 |
KR970704463A (ko) | 1997-09-06 |
JP4277015B2 (ja) | 2009-06-10 |
EP0772630A1 (fr) | 1997-05-14 |
FR2723372A1 (fr) | 1996-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2663550B1 (en) | Substituted benzoazepines as toll-like receptor modulators | |
CN109153675A (zh) | 细胞周期蛋白依赖性激酶9(cdk9)通过cdk9抑制剂与e3连接酶配体的缀合的降解及使用方法 | |
TW201206946A (en) | Compounds for the reduction of beta-amyloid production | |
JP2001527058A (ja) | ノイラミニダーゼ阻害剤として有用な置換シクロペンタン及びシクロペンテン化合物 | |
US8716270B2 (en) | Polymorphic and amorphous salt forms of squalamine dilactate | |
CA3070171A1 (en) | Tlr7/8 antagonists and uses thereof | |
CN102365094A (zh) | 用于预防或者治疗肝炎感染的环孢菌素类似物 | |
JP2000327575A (ja) | ジケトピペラジン誘導体含有炎症疾患治療剤および新規なジケトピペラジン誘導体 | |
TWI332835B (en) | Hemiasterlin derivatives and uses thereof | |
WO1996038464A1 (en) | Antimicrobial sterol conjugates | |
CA3226492A1 (en) | Bicyclic peptide inhibitors of interleukin-23 receptor | |
JP2005511742A (ja) | 重水素化された、置換されたジヒドロフラノン並びに前記化合物を含有する医薬品 | |
JP4277015B2 (ja) | ストレプトグラミン誘導体、その製造およびそれを含む製薬組成物 | |
EP0646596A1 (de) | Nukleinsäure-bindende Oligomere mit C-Verzweigung für Therapie und Diagnostik | |
JP5616628B2 (ja) | ピログルタミン酸誘導体の合成および使用 | |
WO2017070878A1 (zh) | C14-位羟基酯化的雷公藤甲素氨基酸衍生物、及其制备方法和应用 | |
JPH06501944A (ja) | N−(2−アルキル−3−メルカプトグルタリル)−アミノ−ジアザシクロアルカノン誘導体およびそれらのコラゲナーゼ抑制薬としての使用 | |
JPH08277270A (ja) | Aceおよびnepの抑制に有用なアゼピノン化合物 | |
JP2002504560A (ja) | ストレプトグラミン誘導体、製造法及びそれを含有する組成物 | |
JP2005500253A (ja) | トロンビン受容体アンタゴニストとしてのアミノメチルピロロキナゾリン化合物 | |
AU3927600A (en) | Phenylalanine derivatives | |
JP3345814B2 (ja) | 26―(ジアルキルアミノアルキルスルホニル)プリスチナマイシンiibから誘導される新規な塩類 | |
JP2001510849A (ja) | ストレプトグラミン類、それらの製造およびそれらを含有する組成物 | |
JPH03176478A (ja) | 新規なジケトピペラジン誘導体及びこれを有効成分とする免疫抑制剤 | |
JP4326178B2 (ja) | ストレプトグラミン誘導体、それらの製造およびそれらを含有する組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040629 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040929 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20041115 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041221 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050222 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050520 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A133 Effective date: 20060113 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060113 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060207 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060217 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090303 Year of fee payment: 3 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090303 Year of fee payment: 3 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100303 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110303 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120303 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130303 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130303 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140303 Year of fee payment: 8 |
|
LAPS | Cancellation because of no payment of annual fees |